Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk Clark

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Aesthetic Plastic Surgery|November 6, 2004
Altering first impressions after facial plastic surgerySteven Dayan, Kirk Clark, Allan A Ho
Clinical Science (London, England : 1979)|August 24, 2002
Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1aRaviraj Kulathila, Kirk Clark, Paula Savage, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 21, 2009
The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9Raviraj Kulathila, Brian Vash, David Sage, et al.
Veterinary Microbiology|October 27, 2004
Procedures for preventing transmission of foot-and-mouth disease virus (O/TAW/97) by peopleSandra F Amass, Peter W Mason, Juan M Pacheco, et al.
Protein Expression and Purification|February 24, 2018
Full-length myocilin protein is purified from mammalian cells as a dimerParvaneh Katoli, Adarsh Godbole, Michael J Romanowski, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2011
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13Ruben A Tommasi, Sven Weiler, Leslie W McQuire, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activityCorinne J Hackbarth, Dawn Z Chen, Jason G Lewis, et al.
Nature|July 13, 2022
Structure of the MRAS-SHOC2-PP1C phosphatase complexZachary J Hauseman, Michelle Fodor, Anxhela Dhembi, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2008
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological resultsArkadius Pichota, Jeyaraj Duraiswamy, Zheng Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized studyMarc Pelletier, Jie Yang, Mukta Joshi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Aesthetic Plastic Surgery|November 6, 2004
Altering first impressions after facial plastic surgerySteven Dayan, Kirk Clark, Allan A Ho
Clinical Science (London, England : 1979)|August 24, 2002
Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1aRaviraj Kulathila, Kirk Clark, Paula Savage, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 21, 2009
The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9Raviraj Kulathila, Brian Vash, David Sage, et al.
Veterinary Microbiology|October 27, 2004
Procedures for preventing transmission of foot-and-mouth disease virus (O/TAW/97) by peopleSandra F Amass, Peter W Mason, Juan M Pacheco, et al.
Protein Expression and Purification|February 24, 2018
Full-length myocilin protein is purified from mammalian cells as a dimerParvaneh Katoli, Adarsh Godbole, Michael J Romanowski, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2011
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13Ruben A Tommasi, Sven Weiler, Leslie W McQuire, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activityCorinne J Hackbarth, Dawn Z Chen, Jason G Lewis, et al.
Nature|July 13, 2022
Structure of the MRAS-SHOC2-PP1C phosphatase complexZachary J Hauseman, Michelle Fodor, Anxhela Dhembi, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2008
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological resultsArkadius Pichota, Jeyaraj Duraiswamy, Zheng Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized studyMarc Pelletier, Jie Yang, Mukta Joshi, et al.
Pageof 2